Toward a novel experimental model of infection to study American cutaneous leishmaniasis caused by Leishmania braziliensis

Infection and Immunity

Volumn 73, Issue 9, 2005, Pages 5827-5834

  De Moura, Tatiana R ^a   Novais, Fernanda O ^a   Oliveira, Fabiano ^a   Clarêncio, Jorge ^a   Noronha, Almério ^a   Barral, Aldina ^a,b   Brodskyn, Claudia ^a,b   De Oliveira, Camila I ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL UNIVERSITY OF BAHIA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CYTOKINE RELEASE; DISEASE MODEL; EVALUATION; FEMALE; HISTOLOGY; IMMUNE RESPONSE; INFLAMMATORY INFILTRATE; INOCULATION; INTERFERON PRODUCTION; LEISHMANIA BRAZILIENSIS; LYMPH NODE; LYMPHOID ORGAN; MONONUCLEAR CELL; MOUSE; NONHUMAN; PERSISTENT INFECTION; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; REINFECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCAR; SKIN LEISHMANIASIS; SKIN ULCER; STAINING; T LYMPHOCYTE; TH1 CELL; WOUND HEALING;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHEMOKINES, CC; DERMIS; DISEASE MODELS, ANIMAL; EAR, EXTERNAL; FEMALE; INTERFERON TYPE II; LEISHMANIA BRAZILIENSIS; LEISHMANIASIS, CUTANEOUS; LYMPH NODES; MICE; MICE, INBRED BALB C;

EID: 23944521372     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.73.9.5827-5834.2005     Document Type: Article

References (50)

1. Aebischer, T., S. F. Moody, and E. Handman. 1993. Persistence of virulent Leishmania major in murine cutaneous leishmaniasis: a possible hazard for the host. Infect. Immun. 61:220-226.
2. Andrade, Z. A., S. G. Reed, S. B. Roters, and M. Sadigurskj. 1984. Immunopathology of experimental cutaneous leishmaniasis. Am. J. Pathol. 114:137-148.
3. Baldwin, T. M., C. Elso, J. Curtis, L. Buckingham, and E. Handman. 2003. The site of Leishmania major infection determines disease severity and immune responses. Infect. Immun. 71:6830-6834.
4. Barral, A;., M. Barral-Netto, R. Almeida, A. R. de Jesus, G. Grimaldi Junior, E. M. Netto, I. Santos, O. Bacellar, and E. M. Carvalho. 1992. Lymphadenopathy associated with Leishmania braziliensis cutaneous infection. Am. J. Trop. Med. Hyg. 47:587-592.
5. Belkaid, Y., S. Kamhawi, G. Modi, J. Valenzuela, N. Noben-Trauth, E. Rowton, J. Ribeiro, and D. L. Sacks. 1998. Development of a natural model of cutaneous leishmaniasis: powerful effects of vector saliva and saliva preexposure on the long-term outcome of Leishmania major infection in the mouse ear dermis. J. Exp. Med, 188:1941-1953.
6. Belkaid, Y., S. Mendez, R. Lira, N. Kadambi, G. Milon, and D. Sacks. 2000. A natural model of Leishmania major infection reveals a prolonged "silent" phase of parasite amplification in the skin before the onset of lesion formation and immunity. J. Immunol. 165:969-977.
7. Belkaid, Y., C. A. Piccirillo, S. Mendez, E. M. Shevach, and D. L. Sacks. 2002. CD4 + CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature 420:502-507.
8. Belkaid, Y., E. Von Stebut, S. Mendez, R. Lira, E. Caler, S. Bertholet, M. C. Udey, and D. Sacks. 2002. CD8+ T cells are required for primary immunity in C57BL/6 mice following low-dose, intradermal challenge with Leishmania major. J. Immunol. 168:3992-4000.
9. Bhattacharyya, S., S. Ghosh, B. Dasgupta, D, Mazumder, S. Roy, and S. Majumdar. 2002. Chemokine-induced leishmanicidal activity in marine macrophages via the generation of nitric oxide. J. Infect. Dis. 185:1704-1708.
10. Bittencourt, A., and A. Barral. 1991. Evaluation of the histopathological classifications of American cutaneous and mucocutaneous leishmaniasis. Mem. Inst. Oswaldo Cruz 86:51-56.
11. Brodskyn, C., C. I. de Oliveira, A, Barral, and M. Barral-Netto. 2003. Vaccines in leishmaniasis: advances in the last five years. Expert Rev. Vaccines 2:705-717.
12. Castilho, T. M., J. J. Shaw, and L. M. Floeter-Winter. 2003. New PCR assay using glucose-6-phosphate dehydrogenase for identification of Leishmania species. J. Clin. Microbiol. 41:540-546.
13. Chang, K. P. 1978. Leishmania infection of human skin fibroblasts in vitro: absence of phagolysosomal fusion after induced phagocytosis of promastigotes, and their intracellular transformation. Am. J. Trop. Med. Hyg. 27:1084-1096.
14. Childs, G. E., L. K. Lightner, L. McKinney, M. G. Groves, E. E. Price, and L. D. Hendricks. 1984. Inbred mice as model hosts for cutaneous leishmaniasis. I. Resistance and susceptibility to infection with Leishmania braziliensis, L. mexicana. and L. aethiopica. Ann. Trop. Med. Parasitol. 78:25-34.
15. Costa, J. M., P. D. Marsden, E. A. Llanos-Cuentas, E. M. Netto, E. M. Carvalho, A. Barral, A. C. Rosa, C. C. Cuba, A. V. Magalhaes, and A. C. Barreto. 1986. Disseminated cutaneous leishmaniasis in a field clinic in Bahia, Brazil: a report of eight cases. J. Trop. Med. Hyg. 89:319-323.
16. Courret, N., T. Lang, G. Milon, and J. C. Antoine. 2003. Intradermal inoculations of low doses of Leishmania major and Leishmania amazonensis metacyclic promastigotes induce different immunoparasitic processes and status of protection in BALB/c mice. Int. J. Parasitol. 33:1373-1383.
17. Dedet, J. P., A. Ryter, E. Vogt, P. Hosli, and L. P. da Silva. 1983. Uptake and killing of Leishmania mexicana amazonensis amastigotes by human skin fibroblasts. Ann. Trop. Med. Parasitol. 77:35-44.
18. DeKrey, G. K., H. C. Lima, and R. G. Titus. 1998. Analysis of the immune responses of mice to infection with Leishmania braziliensis. Infect. Immun. 66:827-829.
19. Donnelly, K. B., H. C. Lima, and R. G. Titus. 1998. Histologic characterization of experimental cutaneous leishmaniasis in mice infected with Leishmania braziliensis in the presence or absence of sand fly vector salivary gland lysate. J. Parasitol. 84:97-103.
20. Fahey, T. J., III, K. J. Tracey, P. Tekamp-Olson, L. S. Cousens, W. G. Jones, G. T. Shires, A. Cerami, and B. Sherry. 1992. Macrophage inflammatory protein 1 modulates macrophage function. J. Immunol. 148:2764-2769.
21. Gumy, A., J. A. Louis, and P. Launois. 2004. The murine model of infection with Leishmania major and its importance for the deciphering of mechanisms underlying differences in Th cell differentiation in mice from different genetic backgrounds. Int. J. Parasitol. 34:433-444.
22. Indiani de Oliveira, C., M. J. Teixeira, C. R. Teixeira, J. Ramos de Jesus, A. Bomura Rosato, J. Santa da Silva, C. Brodskyn, M. Barral-Netto, and A. Barral. 2004. Leishmania braziliensis isolates differing at the genome level display distinctive features in BALB/c mice. Microbes Infect. 6:977-984.
23. Jones, T. C., W. D. Johnson, Jr., A. C. Barretto, E. Lago, R. Badaro, B. Cerf, S. G. Reed, E. M. Netto, M. S. Tada, T. F, Franca, et al. 1987. Epidemiology of American cutaneous leishmaniasis due to Leishmania braziliensis braziliensis. J. Infect. Dis. 156:73-83.
24. Kupper, T. S., and R. C. Fuhlbrigge. 2004. Immune surveillance in the skin: mechanisms and clinical consequences. Nat. Rev. Immunol. 4:211-222.
25. Leonard, E. J., and T. Yoshimura. 1990, Human monocyte chemoattractant protein-1 (MCP-1). Immunol. Today 11:97-101.
26. Lima, G. M., A. L. Vallochi, U. R. Silva, E. M. Bevilacqua, M. M. Kiffer, and I. A. Abrahamsohn. 1998. The role of poiymorphonuclear leukocytes in the resistance to cutaneous Leishmaniasis. Immunol. Lett. 64:145-151.
27. Lima, H. C., G. K. DeKrey, and R. G. Titus. 1999. Resolution of an infection with Leishmania braziliensis confers complete protection to a subsequent challenge with Leishmania major in BALB/c mice. Mem. Inst. Oswaldo Cruz 94:71-76.
28. Llanos Cuentas, E. A., C. C. Cuba, A. C. Barreto, and P. D. Marsden. 1984. Clinical characteristics of human Leishmania braziliensis braziliensis infections. Trans. R. Soc. Trop. Med. Hyg. 78:845-846.
29. Louis, J., H. Himmelrich, C. Parra-Lopez, F. Tacchini-Cottier, and P. Launois. 1998. Regulation of protective immunity against Leishmania major in mice. Curr. Opin. Immunol. 10:459-464.
30. Marsden, P. D. 1986. Mucosal leishmaniasis ("espundia" Escomel, 1911). Trans. R. Soc. Trop. Med. Hyg. 80:859-876.
31. McMahon-Pratt, D., E. Bennett, and J. R. David. 1982. Monoclonal antibodies that distinguish subspecies of Leishmania braziliensis. J. Immunol. 129:926-927.
32. Mendez, S., S. K. Reckling, C. A. Piccirillo, D. Sacks, and Y. Belkaid. 2004. Role for CD4(+) CD25(+) regulatory T cells in reactivation of persistent leishmaniasis and control of concomitant immunity. J. Exp. Med. 200:201-210.
33. Mendonca, M. G., M. E. de Brito, E. H. Rodrigues, V. Bandeira, M. L. Jardim, and F. G. Abath. 2004. Persistence of Leishmania parasites in scars after clinical cure of American cutaneous leishmaniasis: is there a sterile cure? J. Infect. Dis. 189:1018-1023.
34. Moore, K. J., and G. Matlashewski. 1994. Intracellular infection by Leishmania donovani inhibits macrophage apoptosis. J. Immunol. 152:2930-2937.
35. Neal, R. A., and C. Hale. 1983. A comparative study of susceptibility of inbred and outbred mouse strains compared with hamsters to infection with New World cutaneous leishmaniases. Parasitology 87:7-13.
36. Norsworthy, N. B., J. Sun, D. Elnaiem, G. Lanzaro, and L. Soong. 2004. Sand fly saliva enhances Leishmania amazonensis infection by modulating interleukin-10 production. Infect. Immun. 72:1240-1247.
37. Pinto-da-Silva, L. H., M. Camurate, K. A. Costa, S. M. Oliveira, N. L. da Cunha-e-Silva, and E. M. Saraiva. 2002. Leishmania (Viannia) braziliensis metacyclic promastigotes purified using Bauhinia purpurea lectin are complement resistant and highly infective for macrophages in vitro and hamsters in vivo. Int. J. Parasitol. 32:1371-1377.
38. Porrozzi, R., A. Teva, V. F. Amaral, M. V. Santos da Costa, and G. Grimaldi, Jr. 2004. Cross-immunity experiments between different species or strains of Leishmania in rhesus macaques (Macaca mulatta). Am. J. Trop. Med. Hyg. 71:297-305.
39. Ramirez, J. L., and P. Guevara. 1997. Persistent infections by Leishmania (Viannia) braziliensis. Mem. Inst. Oswaldo Cruz 92:333-338.
40. Reiner, S. L., and R. M. Locksley. 1995. The regulation of immunity to Leishmania major. Annu. Rev. Immunol. 13:151-177.
41. Ribeiro-Gomes, F. L., A. C. Otero, N. A. Gomes, M. C. Moniz-De-Souza, L. Cysne-Finkelstein, A. C. Arnholdt, V. L. Calich, S. G. Coutinho, M. F. Lopes, and G. A. DosReis. 2004. Macrophage interactions with neutrophils regulate Leishmania major infection. J. Immunol. 172:4454-4462.
42. Sacks, D., and N. Noben-Trauth. 2002. The immunology of susceptibility and resistance to Leishmania major in mice. Nat. Rev. Immunol. 2:845-858.
43. Samuelson, J., E. Lerner, R. Tesh, and R. Titus. 1991. A mouse model of Leishmania braziliensis braziliensis infection produced by coinjection with sand fly saliva. J. Exp. Med. 173:49-54.
44. Schubach, A., F. Haddad, M. P. Oliveira-Neto, W. Degrave, C. Pirmez, G. Grimaldi, Jr., and O. Fernandes. 1998. Detection of Leishmania DNA by polymerase chain reaction in scars of treated human patients. J. Infect. Dis. 178:911-914.
45. Schwartzman, J. D., and R. D. Pearson. 1985. The interaction of Leishmania donovani promastigotes and human fibroblasts in vitro. Am. J. Trop. Med. Hyg. 34:850-355.
46. Tacchini-Cottier, F., C. Zweifel, Y. Belkaid, C. Mukankundiye, M. Vasei, P. Launois, G. Milon, and J. A. Louis. 2000. An immunomodulatory function for neutrophils during the induction of a CD4+ Th2 response in BALB/c mice infected with Leishmania major. J. Immunol. 165:2628-2636.
47. Teixeira, M. J., J. D. Fernandes, C. R. Teixeira, B. B. Andrade, M. L. Pompeu. J. Santana da Silva, C. I. Brodskyn, M. Barral-Netto, and A. Barral. 2005. Distinct Leishmania braziliensis isolates induce different paces of chemokine expression patterns. Infect. Immun. 73:1191-1195.
48. Titus, R. G., M. Marchand, T. Boon, and J. A. Louis. 1985. A limiting dilution assay for quantifying Leishmania major in tissues of infected mice. Parasite Immunol. 7:545-555.
49. Titus, R. G., G. Milon, G. Marchal, P. Vassalli, J. C. Cerottini, and J. A. Louis. 1987. Involvement of specific Lyt-2+ T cells in the immunological control of experimentally induced murine cutaneous leishmaniasis. Eur. J. Immunol. 17:1429-1433.
50. Venuprasad, K., S. Chattopadhyay, and B. Saha. 2003. CD28 signaling in neutrophil induces T-cell chemotactic factor(s) modulating T-cell response. Hum. Immunol. 64:38-43.